Table of Content

1 Oncology Injection Drug Market Overview
1.1 Oncology Injection Drug Product Scope
1.2 Oncology Injection Drug Segment by Type
1.2.1 Global Oncology Injection Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Organs
1.2.3 Central Nervous System
1.2.4 Circulatory/Musculoskeletal System
1.2.5 Other
1.3 Oncology Injection Drug Segment by Application
1.3.1 Global Oncology Injection Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Lymphoma
1.3.3 Myeloma
1.3.4 Prostate Cancer
1.3.5 Other
1.4 Oncology Injection Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Oncology Injection Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Oncology Injection Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Oncology Injection Drug Price Trends (2016-2027)

2 Oncology Injection Drug Estimates and Forecasts by Region
2.1 Global Oncology Injection Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Oncology Injection Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Oncology Injection Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Oncology Injection Drug Revenue Market Share by Region (2016-2021)
2.3 Global Oncology Injection Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Oncology Injection Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Oncology Injection Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Oncology Injection Drug Estimates and Projections (2016-2027)
2.4.2 Europe Oncology Injection Drug Estimates and Projections (2016-2027)
2.4.3 China Oncology Injection Drug Estimates and Projections (2016-2027)
2.4.4 Japan Oncology Injection Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Oncology Injection Drug Estimates and Projections (2016-2027)
2.4.6 India Oncology Injection Drug Estimates and Projections (2016-2027)

3 Global Oncology Injection Drug Competition Landscape by Players
3.1 Global Top Oncology Injection Drug Players by Sales (2016-2021)
3.2 Global Top Oncology Injection Drug Players by Revenue (2016-2021)
3.3 Global Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology Injection Drug as of 2020)
3.4 Global Oncology Injection Drug Average Price by Company (2016-2021)
3.5 Manufacturers Oncology Injection Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Oncology Injection Drug Market Size by Type
4.1 Global Oncology Injection Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Oncology Injection Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Oncology Injection Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Oncology Injection Drug Price by Type (2016-2021)
4.2 Global Oncology Injection Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Oncology Injection Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Oncology Injection Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Oncology Injection Drug Price Forecast by Type (2022-2027)

5 Global Oncology Injection Drug Market Size by Application
5.1 Global Oncology Injection Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Oncology Injection Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Oncology Injection Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Oncology Injection Drug Price by Application (2016-2021)
5.2 Global Oncology Injection Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Oncology Injection Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Oncology Injection Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Oncology Injection Drug Price Forecast by Application (2022-2027)

6 North America Oncology Injection Drug Market Facts & Figures
6.1 North America Oncology Injection Drug Sales by Company
6.1.1 North America Oncology Injection Drug Sales by Company (2016-2021)
6.1.2 North America Oncology Injection Drug Revenue by Company (2016-2021)
6.2 North America Oncology Injection Drug Sales Breakdown by Type
6.2.1 North America Oncology Injection Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Oncology Injection Drug Sales Breakdown by Type (2022-2027)
6.3 North America Oncology Injection Drug Sales Breakdown by Application
6.3.1 North America Oncology Injection Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Oncology Injection Drug Sales Breakdown by Application (2022-2027)

7 Europe Oncology Injection Drug Market Facts & Figures
7.1 Europe Oncology Injection Drug Sales by Company
7.1.1 Europe Oncology Injection Drug Sales by Company (2016-2021)
7.1.2 Europe Oncology Injection Drug Revenue by Company (2016-2021)
7.2 Europe Oncology Injection Drug Sales Breakdown by Type
7.2.1 Europe Oncology Injection Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Oncology Injection Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Oncology Injection Drug Sales Breakdown by Application
7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)

8 China Oncology Injection Drug Market Facts & Figures
8.1 China Oncology Injection Drug Sales by Company
8.1.1 China Oncology Injection Drug Sales by Company (2016-2021)
8.1.2 China Oncology Injection Drug Revenue by Company (2016-2021)
8.2 China Oncology Injection Drug Sales Breakdown by Type
8.2.1 China Oncology Injection Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Oncology Injection Drug Sales Breakdown by Type (2022-2027)
8.3 China Oncology Injection Drug Sales Breakdown by Application
8.3.1 China 164 Sales Breakdown by Application (2016-2021)
8.3.2 China 164 Sales Breakdown by Application (2022-2027)

9 Japan Oncology Injection Drug Market Facts & Figures
9.1 Japan Oncology Injection Drug Sales by Company
9.1.1 Japan Oncology Injection Drug Sales by Company (2016-2021)
9.1.2 Japan Oncology Injection Drug Revenue by Company (2016-2021)
9.2 Japan Oncology Injection Drug Sales Breakdown by Type
9.2.1 Japan Oncology Injection Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Oncology Injection Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Oncology Injection Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Oncology Injection Drug Market Facts & Figures
10.1 Southeast Asia Oncology Injection Drug Sales by Company
10.1.1 Southeast Asia Oncology Injection Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Oncology Injection Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Oncology Injection Drug Sales Breakdown by Type
10.2.1 Southeast Asia Oncology Injection Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Oncology Injection Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Oncology Injection Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Oncology Injection Drug Market Facts & Figures
11.1 India Oncology Injection Drug Sales by Company
11.1.1 India Oncology Injection Drug Sales by Company (2016-2021)
11.1.2 India Oncology Injection Drug Revenue by Company (2016-2021)
11.2 India Oncology Injection Drug Sales Breakdown by Type
11.2.1 India Oncology Injection Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Oncology Injection Drug Sales Breakdown by Type (2022-2027)
11.3 India Oncology Injection Drug Sales Breakdown by Application
11.3.1 India Oncology Injection Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Oncology Injection Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Oncology Injection Drug Business
12.1 Taj Oncology
12.1.1 Taj Oncology Corporation Information
12.1.2 Taj Oncology Business Overview
12.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Taj Oncology Oncology Injection Drug Products Offered
12.1.5 Taj Oncology Recent Development
12.2 S.G. Biopharm
12.2.1 S.G. Biopharm Corporation Information
12.2.2 S.G. Biopharm Business Overview
12.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 S.G. Biopharm Oncology Injection Drug Products Offered
12.2.5 S.G. Biopharm Recent Development
12.3 AdvaCare
12.3.1 AdvaCare Corporation Information
12.3.2 AdvaCare Business Overview
12.3.3 AdvaCare Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 AdvaCare Oncology Injection Drug Products Offered
12.3.5 AdvaCare Recent Development
12.4 Merrimack
12.4.1 Merrimack Corporation Information
12.4.2 Merrimack Business Overview
12.4.3 Merrimack Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merrimack Oncology Injection Drug Products Offered
12.4.5 Merrimack Recent Development
12.5 Celgene
12.5.1 Celgene Corporation Information
12.5.2 Celgene Business Overview
12.5.3 Celgene Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Celgene Oncology Injection Drug Products Offered
12.5.5 Celgene Recent Development
12.6 Allos Therapeutics
12.6.1 Allos Therapeutics Corporation Information
12.6.2 Allos Therapeutics Business Overview
12.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Allos Therapeutics Oncology Injection Drug Products Offered
12.6.5 Allos Therapeutics Recent Development
12.7 Ferring Pharmaceuticals
12.7.1 Ferring Pharmaceuticals Corporation Information
12.7.2 Ferring Pharmaceuticals Business Overview
12.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ferring Pharmaceuticals Oncology Injection Drug Products Offered
12.7.5 Ferring Pharmaceuticals Recent Development
12.8 Genzyme
12.8.1 Genzyme Corporation Information
12.8.2 Genzyme Business Overview
12.8.3 Genzyme Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Genzyme Oncology Injection Drug Products Offered
12.8.5 Genzyme Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Corporation Information
12.9.2 Eli Lilly Business Overview
12.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Eli Lilly Oncology Injection Drug Products Offered
12.9.5 Eli Lilly Recent Development
12.10 Praecis Pharmaceuticals
12.10.1 Praecis Pharmaceuticals Corporation Information
12.10.2 Praecis Pharmaceuticals Business Overview
12.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Praecis Pharmaceuticals Oncology Injection Drug Products Offered
12.10.5 Praecis Pharmaceuticals Recent Development
12.11 Millennium Pharmaceuticals
12.11.1 Millennium Pharmaceuticals Corporation Information
12.11.2 Millennium Pharmaceuticals Business Overview
12.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Millennium Pharmaceuticals Oncology Injection Drug Products Offered
12.11.5 Millennium Pharmaceuticals Recent Development
12.12 Debiopharm
12.12.1 Debiopharm Corporation Information
12.12.2 Debiopharm Business Overview
12.12.3 Debiopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Debiopharm Oncology Injection Drug Products Offered
12.12.5 Debiopharm Recent Development
12.13 Alza
12.13.1 Alza Corporation Information
12.13.2 Alza Business Overview
12.13.3 Alza Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Alza Oncology Injection Drug Products Offered
12.13.5 Alza Recent Development
12.14 CordenPharma
12.14.1 CordenPharma Corporation Information
12.14.2 CordenPharma Business Overview
12.14.3 CordenPharma Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 CordenPharma Oncology Injection Drug Products Offered
12.14.5 CordenPharma Recent Development
12.15 Pharmascience
12.15.1 Pharmascience Corporation Information
12.15.2 Pharmascience Business Overview
12.15.3 Pharmascience Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Pharmascience Oncology Injection Drug Products Offered
12.15.5 Pharmascience Recent Development

13 Oncology Injection Drug Manufacturing Cost Analysis
13.1 Oncology Injection Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Oncology Injection Drug
13.4 Oncology Injection Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Oncology Injection Drug Distributors List
14.3 Oncology Injection Drug Customers

15 Market Dynamics
15.1 Oncology Injection Drug Market Trends
15.2 Oncology Injection Drug Drivers
15.3 Oncology Injection Drug Market Challenges
15.4 Oncology Injection Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Oncology Injection Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Oncology Injection Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Oncology Injection Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Oncology Injection Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Oncology Injection Drug Sales Market Share by Region (2016-2021)
Table 6. Global Oncology Injection Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Oncology Injection Drug Revenue Share by Region (2016-2021)
Table 8. Global Oncology Injection Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Oncology Injection Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Oncology Injection Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Oncology Injection Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Oncology Injection Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Oncology Injection Drug Sales Share by Company (2016-2021)
Table 14. Global Oncology Injection Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Oncology Injection Drug Revenue Share by Company (2016-2021)
Table 16. Global Oncology Injection Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Injection Drug as of 2020)
Table 17. Global Oncology Injection Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Oncology Injection Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Oncology Injection Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Oncology Injection Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Oncology Injection Drug Sales Share by Type (2016-2021)
Table 23. Global Oncology Injection Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Oncology Injection Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Oncology Injection Drug Sales Share by Type (2022-2027)
Table 26. Global Oncology Injection Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Oncology Injection Drug Revenue Share by Type (2022-2027)
Table 28. Global Oncology Injection Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Oncology Injection Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Oncology Injection Drug Sales Share by Application (2016-2021)
Table 31. Global Oncology Injection Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Oncology Injection Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Oncology Injection Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Oncology Injection Drug Sales Share by Application (2022-2027)
Table 35. Global Oncology Injection Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Oncology Injection Drug Revenue Share by Application (2022-2027)
Table 37. Global Oncology Injection Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Oncology Injection Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Oncology Injection Drug Sales Market Share by Company (2016-2021)
Table 40. North America Oncology Injection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Oncology Injection Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Oncology Injection Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Oncology Injection Drug Sales Market Share by Type (2016-2021)
Table 44. North America Oncology Injection Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Oncology Injection Drug Sales Market Share by Type (2022-2027)
Table 46. North America Oncology Injection Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Oncology Injection Drug Sales Market Share by Application (2016-2021)
Table 48. North America Oncology Injection Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Oncology Injection Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Oncology Injection Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Oncology Injection Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Oncology Injection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Oncology Injection Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Oncology Injection Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Oncology Injection Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Oncology Injection Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Oncology Injection Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Oncology Injection Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Oncology Injection Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Oncology Injection Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Oncology Injection Drug Sales Market Share by Application (2022-2027)
Table 62. China Oncology Injection Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Oncology Injection Drug Sales Market Share by Company (2016-2021)
Table 64. China Oncology Injection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Oncology Injection Drug Revenue Market Share by Company (2016-2021)
Table 66. China Oncology Injection Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Oncology Injection Drug Sales Market Share by Type (2016-2021)
Table 68. China Oncology Injection Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Oncology Injection Drug Sales Market Share by Type (2022-2027)
Table 70. China Oncology Injection Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Oncology Injection Drug Sales Market Share by Application (2016-2021)
Table 72. China Oncology Injection Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Oncology Injection Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Oncology Injection Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Oncology Injection Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Oncology Injection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Oncology Injection Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Oncology Injection Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Oncology Injection Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Oncology Injection Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Oncology Injection Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Oncology Injection Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Oncology Injection Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Oncology Injection Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Oncology Injection Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Oncology Injection Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Oncology Injection Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Oncology Injection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Oncology Injection Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Oncology Injection Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Oncology Injection Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Oncology Injection Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Oncology Injection Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Oncology Injection Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Oncology Injection Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Oncology Injection Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Oncology Injection Drug Sales Market Share by Application (2022-2027)
Table 98. India Oncology Injection Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Oncology Injection Drug Sales Market Share by Company (2016-2021)
Table 100. India Oncology Injection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Oncology Injection Drug Revenue Market Share by Company (2016-2021)
Table 102. India Oncology Injection Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Oncology Injection Drug Sales Market Share by Type (2016-2021)
Table 104. India Oncology Injection Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Oncology Injection Drug Sales Market Share by Type (2022-2027)
Table 106. India Oncology Injection Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Oncology Injection Drug Sales Market Share by Application (2016-2021)
Table 108. India Oncology Injection Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Oncology Injection Drug Sales Market Share by Application (2022-2027)
Table 110. Taj Oncology Corporation Information
Table 111. Taj Oncology Description and Business Overview
Table 112. Taj Oncology Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Taj Oncology Oncology Injection Drug Product
Table 114. Taj Oncology Recent Development
Table 115. S.G. Biopharm Corporation Information
Table 116. S.G. Biopharm Description and Business Overview
Table 117. S.G. Biopharm Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. S.G. Biopharm Oncology Injection Drug Product
Table 119. S.G. Biopharm Recent Development
Table 120. AdvaCare Corporation Information
Table 121. AdvaCare Description and Business Overview
Table 122. AdvaCare Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. AdvaCare Oncology Injection Drug Product
Table 124. AdvaCare Recent Development
Table 125. Merrimack Corporation Information
Table 126. Merrimack Description and Business Overview
Table 127. Merrimack Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Merrimack Oncology Injection Drug Product
Table 129. Merrimack Recent Development
Table 130. Celgene Corporation Information
Table 131. Celgene Description and Business Overview
Table 132. Celgene Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Celgene Oncology Injection Drug Product
Table 134. Celgene Recent Development
Table 135. Allos Therapeutics Corporation Information
Table 136. Allos Therapeutics Description and Business Overview
Table 137. Allos Therapeutics Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Allos Therapeutics Oncology Injection Drug Product
Table 139. Allos Therapeutics Recent Development
Table 140. Ferring Pharmaceuticals Corporation Information
Table 141. Ferring Pharmaceuticals Description and Business Overview
Table 142. Ferring Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Ferring Pharmaceuticals Oncology Injection Drug Product
Table 144. Ferring Pharmaceuticals Recent Development
Table 145. Genzyme Corporation Information
Table 146. Genzyme Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Genzyme Description and Business Overview
Table 148. Genzyme Oncology Injection Drug Product
Table 149. Genzyme Recent Development
Table 150. Eli Lilly Corporation Information
Table 151. Eli Lilly Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Eli Lilly Description and Business Overview
Table 153. Eli Lilly Oncology Injection Drug Product
Table 154. Eli Lilly Recent Development
Table 155. Praecis Pharmaceuticals Corporation Information
Table 156. Praecis Pharmaceuticals Description and Business Overview
Table 157. Praecis Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Praecis Pharmaceuticals Oncology Injection Drug Product
Table 159. Praecis Pharmaceuticals Recent Development
Table 160. Millennium Pharmaceuticals Corporation Information
Table 161. Millennium Pharmaceuticals Description and Business Overview
Table 162. Millennium Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Millennium Pharmaceuticals Oncology Injection Drug Product
Table 164. Millennium Pharmaceuticals Recent Development
Table 165. Debiopharm Corporation Information
Table 166. Debiopharm Description and Business Overview
Table 167. Debiopharm Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Debiopharm Oncology Injection Drug Product
Table 169. Debiopharm Recent Development
Table 170. Alza Corporation Information
Table 171. Alza Description and Business Overview
Table 172. Alza Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Alza Oncology Injection Drug Product
Table 174. Alza Recent Development
Table 175. CordenPharma Corporation Information
Table 176. CordenPharma Description and Business Overview
Table 177. CordenPharma Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. CordenPharma Oncology Injection Drug Product
Table 179. CordenPharma Recent Development
Table 180. Pharmascience Corporation Information
Table 181. Pharmascience Description and Business Overview
Table 182. Pharmascience Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Pharmascience Oncology Injection Drug Product
Table 184. Pharmascience Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Oncology Injection Drug Distributors List
Table 188. Oncology Injection Drug Customers List
Table 189. Oncology Injection Drug Market Trends
Table 190. Oncology Injection Drug Market Drivers
Table 191. Oncology Injection Drug Market Challenges
Table 192. Oncology Injection Drug Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology Injection Drug Product Picture
Figure 2. Global Oncology Injection Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Organs Product Picture
Figure 4. Central Nervous System Product Picture
Figure 5. Circulatory/Musculoskeletal System Product Picture
Figure 6. Other Product Picture
Figure 7. Global Oncology Injection Drug Sales Market Share by Application in 2021 & 2027
Figure 8. Lymphoma Examples
Figure 9. Myeloma Examples
Figure 10. Prostate Cancer Examples
Figure 11. Other Examples
Figure 12. Global Oncology Injection Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Oncology Injection Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Oncology Injection Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 15. Global Oncology Injection Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 16. Global Oncology Injection Drug Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Oncology Injection Drug Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Oncology Injection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Oncology Injection Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 20. Europe Oncology Injection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Oncology Injection Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Oncology Injection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Oncology Injection Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Oncology Injection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Oncology Injection Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Oncology Injection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Oncology Injection Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Oncology Injection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Oncology Injection Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Oncology Injection Drug Players Market Share by Revenue in Oncology Injection Drug: 2016 & 2020
Figure 31. Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Oncology Injection Drug Revenue Share by Type (2016-2021)
Figure 33. Global Oncology Injection Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Oncology Injection Drug Revenue Share by Application (2016-2021)
Figure 35. Global Oncology Injection Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Oncology Injection Drug Sales Market Share by Type in 2020
Figure 37. North America Oncology Injection Drug Sales Market Share by Application in 2020
Figure 38. Europe Oncology Injection Drug Sales Market Share by Type in 2020
Figure 39. Europe Oncology Injection Drug Sales Market Share by Application in 2020
Figure 40. China Oncology Injection Drug Sales Market Share by Type in 2020
Figure 41. China Oncology Injection Drug Sales Market Share by Application in 2020
Figure 42. Japan Oncology Injection Drug Sales Market Share by Type in 2020
Figure 43. Japan Oncology Injection Drug Sales Market Share by Application in 2020
Figure 44. Southeast Asia Oncology Injection Drug Sales Market Share by Type in 2020
Figure 45. Southeast Asia Oncology Injection Drug Sales Market Share by Application in 2020
Figure 46. India Oncology Injection Drug Sales Market Share by Type in 2020
Figure 47. India Oncology Injection Drug Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Oncology Injection Drug
Figure 50. Manufacturing Process Analysis of Oncology Injection Drug
Figure 51. Oncology Injection Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed